NeuroPace, Inc. (NPCE) Balance Sheet

NASDAQ: NPCEAssets, liabilities, debt and equity over 7 years.

NPCE balance sheet, 2025

December 31, 2025 · U.S. dollars

$105.6M assets = $86.5M liabilities + $19.0M equity

What it owns$105.6MCash & ST investments: $61.1M (57.8%)Cash & ST investments$61.1M · 58%Receivables: $14.7M (13.9%)Receivables$14.7M · 14%Inventory: $16.9M (16.0%)Inventory$16.9M · 16%Other current: $1.4M (1.4%)PP&E: $11.3M (10.7%)PP&E $11.3MOther non-current: $235,000 (0.2%)=How it is financed$105.6MCurrent liabilities: $17.8M (16.9%)Current liabilities$17.8M · 17%Long-term debt: $58.9M (55.8%)Long-term debt$58.9M · 56%Other LT liabilities: $9.8M (9.3%)Other LT liabilities $9.8MShareholders’ equity: $19.0M (18.0%)Shareholders’ equity$19.0M · 18%

Both columns are drawn to the same scale: what NPCE owns equals what it owes plus shareholders’ equity. Hover a block for its value.

NPCE financial health

Current ratio5.28
Comfortable · current assets cover current liabilities 5.28×
Debt / equity3.72
High leverage · $3.72 of debt for each $1 of equity
Equity / assets18.0%
Thin equity · of assets funded by shareholders
Cash / debt86.2%
Partial cover · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

NPCE balance sheet trends, 2019–2025

NeuroPace, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$21.1M2019$105.6M2025+30.8%/yr
Total liabilities$150.4M2019$86.5M2025−8.8%/yr
Shareholders’ equity−$129.3M2019$19.0M2025—
Cash & short-term investments$5.1M2019$61.1M2025+51.3%/yr
Total debt$62.8M2019$70.8M2025+2.0%/yr
Net cash (debt)−$57.7M2019−$9.8M2025+$47.9M
Working capital−$54.9M2019$76.3M2025+$131.1M
Book value per share−$11.652019$0.582025—
Current ratio0.2720195.282025+5.01
Debt / equity0.6820213.722025+3.04
Shares outstanding11.1M201932.7M2025+19.7%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

NPCE assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

NPCE liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

NPCE debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

NPCE balance sheet

NeuroPace, Inc. annual balance sheet
2025202420232022202120202019
Assets
Cash & short-term investments$61.1M$52.8M$66.5M$77.4M$115.6M$38.1M$5.1M
Cash & equivalents$21.7M$13.4M$18.1M$6.6M$19.2M$26.4M$4.1M
Short-term investments$39.4M$39.3M$48.4M$70.8M$96.4M$11.7M$969,000
Receivables$14.7M$12.9M$12.3M$7.5M$7.1M$8.4M$6.0M
Inventory$16.9M$13.4M$11.2M$9.7M$7.8M$6.9M$7.9M
Other current assets$1.4M$2.4M$2.7M$3.1M$2.3M$1.2M$1.3M
Total current assets$94.1M$81.3M$92.7M$97.7M$132.8M$54.6M$20.3M
Property, plant & equipment (net)$11.3M$12.9M$14.4M$15.9M$603,000$515,000$810,000
Goodwill & intangible assets$0$0$0$0$0$0$0
Long-term investments$0$0$0$0$0$0$0
Other non-current assets$235,000$413,000$524,000$490,000$143,000$873,000$25,000
Total assets$105.6M$94.6M$107.7M$114.1M$133.6M$56.0M$21.1M
Liabilities
Accounts payable$2.2M$3.0M$2.3M$2.1M$1.4M$949,000$903,000
Short-term debt$2.1M$1.9M$1.6M$1.4M—$2.0M$62.8M
Deferred revenue$141,000$555,000$1.1M———$6.7M
Total current liabilities$17.8M$15.2M$16.2M$11.0M$9.3M$9.6M$75.1M
Long-term debt$58.9M$59.5M$57.0M$52.9M$49.8M$50.8M$0
Lease obligations$12.0M$13.8M$15.4M$16.9M$0——
Other long-term liabilities$9.8M$12.0M$13.8M$15.4M$911,000$143.4M$75.3M
Total liabilities$86.5M$86.6M$87.0M$79.3M$60.1M$203.8M$150.4M
Shareholders' equity
Common stock & paid-in capital$34,000$30,000$28,000$25,000$24,000$1,000$1,000
Retained earnings (deficit)−$552.4M−$531.0M−$503.8M−$470.9M−$423.8M−$387.7M−$363.6M
Accumulated other comprehensive income——$0−$1.1M−$272,000$33,000$1,000
Total shareholders' equity$19.0M$8.0M$20.7M$34.8M$73.5M−$147.8M−$129.3M
Key figures
Total debt$70.8M$73.3M$72.4M$69.8M$49.8M$52.9M$62.8M
Net cash (debt)−$9.8M−$20.6M−$5.9M$7.6M$65.7M−$14.8M−$57.7M
Working capital$76.3M$66.2M$76.5M$86.7M$123.5M$45.0M−$54.9M
Tangible book value$19.0M$8.0M$20.7M$34.8M$73.5M−$147.8M−$129.3M
Book value per share$0.58$0.28$0.80$1.41$4.43−$13.31−$11.65
Shares outstanding32.7M29.1M25.9M24.6M16.6M11.1M11.1M
Current ratio5.285.375.718.9014.285.690.27
Quick ratio4.254.334.857.7313.194.840.15
Debt / equity3.729.153.512.010.68——
Equity / assets18.0%8.5%19.2%30.5%55.0%−264.2%−613.2%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 3, 2026); data from EODHD.

NPCE financial position

At the end of fiscal 2025 (December 31, 2025), NeuroPace had total assets of $105.6 million (up 11.5% from a year earlier), total liabilities of $86.5 million and shareholders' equity of $19.0 million. It held $61.1 million in cash and short-term investments against $70.8 million of debt, net debt of $9.8 million. Its current ratio was 5.28. In the latest quarter (ended June 30, 2026) total assets were $97.0 million and equity $11.9 million.

Related: NPCE income statement, NPCE cash flow statement, NPCE key metrics. See the NPCE stock overview for the latest quote and news.

NPCE balance sheet FAQ

What are NeuroPace's total assets?

NeuroPace reported total assets of $105.6 million at the end of fiscal 2025 (December 31, 2025), compared with $94.6 million a year earlier.

How much debt does NeuroPace have?

NeuroPace had $70.8 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 3.72.

How much cash does NeuroPace have?

NeuroPace held $61.1 million in cash and short-term investments at the end of fiscal 2025; with $70.8 million of debt that is net debt of $9.8 million.

What is NeuroPace's book value?

NeuroPace's shareholders' equity (book value) was $19.0 million at the end of fiscal 2025, or $0.58 per share.

What is NeuroPace's current ratio?

NeuroPace had current assets of $94.1 million and current liabilities of $17.8 million, a current ratio of 5.28 (it can cover its short-term obligations).

Medical Devices: balance sheet